Literature DB >> 16843333

Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers.

A L Cooper1, L Gibbons, M A Horan, R A Little, N J Rothwell.   

Abstract

The effect of dietary fish oil supplementation on acute phase responses to intramuscular injection of typhoid vaccine, and in vitro cytokine production, was investigated in human volunteers. Half of the subjects supplemented their normal diet with 4.5 g/day of fish oil for 6-8 weeks. Injection of typhoid vaccine in unsupplemented subjects caused an increase in white cell count, resting heart rate, metabolic rate, oxygen consumption, and oral temperature. Fish oil supplementation inhibited the tachycardia and attenuated the maximal increases in oral temperature and metabolic rate following typhoid vaccine. However, interpretation of these latter results were complicated by similarly attenuated responses in saline-injected subjects. The in vitro production of interleukin-1 and interleukin-6 from whole blood was suppressed by fish oil supplementation, however, production of tumor necrosis factor alpha was not significantly altered. Fish oil supplementation may therefore provide a non-pharmacological approach of attenuating several of the responses associated with injury and infection and this may be related to reduced cytokine (IL-1 and IL-6) production.

Entities:  

Year:  1993        PMID: 16843333     DOI: 10.1016/0261-5614(93)90027-2

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  16 in total

Review 1.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

Review 2.  n-3 polyunsaturated fatty acids and human cytokine synthesis.

Authors:  S Endres
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

3.  Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects.

Authors:  Thomas-Thi Pluess; Daniel Hayoz; Mette M Berger; Luc Tappy; Jean-Pierre Revelly; Burkhard Michaeli; Yvon A Carpentier; René L Chioléro
Journal:  Intensive Care Med       Date:  2007-03-22       Impact factor: 17.440

Review 4.  Polyunsaturated fatty acids, inflammation, and immunity.

Authors:  P C Calder
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

5.  n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?

Authors:  M Kilian; I Heukamp; J I Gregor; C Bretthauer; M K Walz; C A Jacobi; H Lochs; I Schimke; H Guski; F A Wenger
Journal:  Int J Colorectal Dis       Date:  2005-04-29       Impact factor: 2.571

6.  Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults.

Authors:  F Thies; E A Miles; G Nebe-von-Caron; J R Powell; T L Hurst; E A Newsholme; P C Calder
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

Review 7.  Fish consumption and risk of gastrointestinal cancers: a meta-analysis of cohort studies.

Authors:  Xiao-Feng Yu; Jian Zou; Jie Dong
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

8.  Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice.

Authors:  S Sadeghi; F A Wallace; P C Calder
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

9.  Nutrition intervention: a strategy against systemic inflammatory syndrome.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-04-14       Impact factor: 4.016

Review 10.  The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Paul W Wales
Journal:  Pediatr Surg Int       Date:  2008-05-27       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.